Tort litigation trends, major verdicts make news in 2011 
Published: January 5, 2012
Tags: asbestos, Botox, brain fog, brain injury, class action, erectile dysfunction, failure to warn, frakking, hair loss, health risks, hepatitis, implied preemption, mesothelioma, natural gas, nuisance, pelvic mesh, Propecia, property devaluation, Proscar, technology, tort claims, tort climate, Twiqbal, U.S. Supreme Court
The past year featured a flurry of activity on the personal injury and tort scene, with several new drug and device developments, significant U.S. Supreme Court rulings and some staggering verdicts.
Here’s a wrap-up of the highlights of personal injury and
» Continue Reading.
Failure-to-warn lawsuits over hair loss drug on the rise
By:
Sylvia Hsieh
Published: December 20, 2011
Tags: failure to warn, hair loss, prescription drugs, Propecia, Proscar, side effects
Lawsuits over the hair loss drugs Propecia and Proscar have been filed in federal and state courts alleging side effects that include erectile dysfunction, infertility, depression and suicide.
Prempro breast cancer cases settle after jury awards $76 million
By:
Sylvia Hsieh
Published: December 15, 2011
Tags: breast cancer, failure to warn, Pennsylvania, Premarin, Prempro, prescription drugs, Provera
After a jury in Philadelphia awarded $76 million in compensatory damages to three women who claimed that the hormone therapy drugs Prempro, Premarin and Provera caused their breast cancer, drug maker Wyeth Pharmaceuticals settled the cases for a confidential amount.
Railroad preemption case lands at Supreme Court
By:
Kimberly Atkins
Published: November 9, 2011
Tags: failure to warn, Locomotive Inspection Act, preemption, Supreme Court
WASHINGTON – The justices of the U.S. Supreme Court are set to decide whether a state law tort suit involving a railroad worker who died from on-the-job asbestos exposure is preempted by a federal railroad inspection law.
Zoloft birth defect suit filed in Ohio
Published: October 14, 2011
Tags: anti-depressants, birth defects, defective manufacturing, design defect, failure to warn, FDA, Pfizer, selective serotonin reuptake inhibitors, SSRI, Zoloft
A woman’s ingestion of the antidepressant Zoloft during pregnancy caused a fatal birth defect in her child, according to a new lawsuit filed against drug make Pfizer in Ohio state court.
Man awarded $48 million in Motrin illness case
Published: October 4, 2011
Tags: California, failure to warn, Motrin, skin disorder
A jury has awarded $48.1 million to a Westchester, Calif. man with a rare, severe skin disorder that he said was caused by the pain reliever Motrin.
Discovery expanded in Yaz, Yasmin multidistrict litigation
Published: August 3, 2011
Tags: Bayer, birth control, Discovery, drug litigation, failure to warn, MDL, multidistrict litigation, Yasmin, Yaz
Discovery in the multidistrict litigation over the birth control drugs Yaz/Yasmin has been expanded beyond the 24 selected bellwether cases.
Aluminum bat maker liable for pitcher’s death
Published: July 26, 2011
Tags: failure to warn, product liability, strict liability
An aluminum baseball bat manufacturer is liable for the death of an 18-year-old pitcher who was struck in the head by a batted ball, the Montana Supreme Court has ruled in affirming an $850,000 jury verdict.
New suits filed over Zimmer NexGen knee replacements
By:
Sylvia Hsieh
Published: June 22, 2011
Tags: failure to warn, NexGen knee replacements, product liability
About two dozen lawsuits have been filed around the country alleging that Zimmer NexGen knee replacements are defective and the company failed to warn that they have a high rate of failure requiring additional revision surgery.
Court narrows suit of woman injured by broken forceps
Published: June 21, 2011
Tags: design defect, failure to warn, product liability, strict liability
A federal judge in Baltimore has applied Virginia law in dismissing strict-liability claims against the maker of forceps that broke inside a Maryland woman undergoing a hysterectomy.
SUBSCRIBERS: Did you receive the new Lawyers USA Weekly Update in your inbox on Monday?
If not, click here to register and learn more now.
